BB&T Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$5.4M Sell
209,294
-300,602
-59% -$7.6M 0.05% 379
2019
Q2
$13M Buy
509,896
+1,440
+0.3% +$35.6K 0.12% 228
2019
Q1
$13.3M Sell
508,456
-41,016
-7% -$1.01M 0.13% 218
2018
Q4
$12.7M Sell
549,472
-42,276
-7% -$939K 0.14% 197
2018
Q3
$13.9M Buy
591,748
+8,904
+2% +$217K 0.14% 211
2018
Q2
$13.4M Buy
582,844
+40,350
+7% +$959K 0.14% 200
2018
Q1
$13.4M Buy
542,494
+42,032
+8% +$1.1M 0.15% 189
2017
Q4
$13.4M Sell
500,462
-95,060
-16% -$2.42M 0.17% 157
2017
Q3
$14.3M Sell
595,522
-6,222
-1% -$141K 0.2% 140
2017
Q2
$12.9M Buy
601,744
+38,034
+7% +$767K 0.19% 150
2017
Q1
$9.66M Buy
563,710
+350,596
+165% +$6.1M 0.13% 196
2016
Q4
$4.43M Hold
213,114
0.06% 294
2016
Q3
$4.43M Buy
213,114
+16,280
+8% +$404K 0.07% 290
2016
Q2
$5.29M Buy
196,834
+59,724
+44% +$1.64M 0.08% 259
2016
Q1
$3.71M Sell
137,110
-5,888
-4% -$158K 0.06% 291
2015
Q4
$4.15M Buy
142,998
+11,348
+9% +$314K 0.09% 222
2015
Q3
$3.57M Buy
131,650
+4,498
+4% +$127K 0.08% 231
2015
Q2
$3.48M Sell
127,152
-38,486
-23% -$1.08M 0.07% 240
2015
Q1
$44.2M Buy
165,638
+2,554
+2% +$58.8K 0.1% 184
2014
Q4
$34.5M Buy
163,084
+4,856
+3% +$108K 0.08% 213
2014
Q3
$37.7M Buy
158,228
+1,600
+1% +$36.8K 0.09% 198
2014
Q2
$36.2M Buy
156,628
+39,568
+34% +$874K 0.09% 208
2014
Q1
$26.7M Buy
117,060
+3,970
+4% +$84.6K 0.07% 222
2013
Q4
$20.9M Buy
113,090
+14,330
+15% +$250K 0.06% 246
2013
Q3
$16.7M Buy
98,760
+13,100
+15% +$220K 0.05% 255
2013
Q2
$13.3K Buy
+85,660
New +$1.43M 0.04% 269

Other funds holding NVO